Skip to main content
Premium Trial:

Request an Annual Quote

... and Pays Roche $27.5M to License RT-PCR Technology for IVD Use

NEW YORK, July 17 (GenomeWeb News) - Beckman Coulter today said it has acquired an in vitro diagnostics product license to all of Roche's real-time PCR patents and pending patent applications.

 

In exchange Beckman Coulter will pay Roche a one-time license fee of $27.5 million and will also pay royalties on sales of all licensed products.

Beckman recently settled a patent-infringement suit with ABI that enabled it to license thermal cycler technology for RT-PCR instrumentation. The Roche license, meantime, "gives our company the intellectual property required to meet the molecular testing needs of routine labs for an automated, fully integrated system," Beckman CEO Scott Garrett said in a statement.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.